News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
33,377 Results
Type
Article (2543)
Company Profile (2)
Press Release (30832)
Section
Business (7078)
Career Advice (6)
Deals (1036)
Drug Delivery (4)
Drug Development (10397)
FDA (1273)
Job Trends (1187)
News (18675)
Policy (1578)
Tag
Academia (88)
Accelerated approval (5)
Adcomms (4)
Alliances (1776)
ALS (2)
Alzheimer's disease (28)
Antibody-drug conjugate (ADC) (134)
Approvals (1340)
Artificial intelligence (15)
Autoimmune disease (4)
Bankruptcy (4)
Best Places to Work (1182)
Biosimilars (8)
Biotechnology (2)
Bladder cancer (63)
Brain cancer (7)
Breast cancer (415)
Cancer (1918)
Cardiovascular disease (4)
Career advice (6)
CAR-T (14)
Cell therapy (55)
Cervical cancer (16)
Clinical research (9689)
Collaboration (132)
Compensation (39)
Complete response letters (3)
COVID-19 (102)
CRISPR (1)
C-suite (31)
Cystic fibrosis (2)
Data (956)
Depression (1)
Diabetes (2)
Diagnostics (370)
Drug discovery (7)
Drug pricing (1)
Duchenne muscular dystrophy (6)
Earnings (4502)
Editorial (1)
Events (6159)
Executive appointments (28)
FDA (1613)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (73)
Gene editing (5)
Gene therapy (14)
GLP-1 (37)
Government (232)
Guidances (38)
Healthcare (915)
HIV (2)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (30)
Immuno-oncology (22)
Indications (20)
Infectious disease (110)
Inflammatory bowel disease (1)
Influenza (2)
Intellectual property (16)
IPO (690)
Job creations (79)
Job search strategy (6)
JPM (3)
Kidney cancer (12)
Layoffs (44)
Legal (64)
Liver cancer (34)
Lung cancer (363)
Lymphoma (39)
Manufacturing (29)
Medical device (139)
Medtech (140)
Mergers & acquisitions (386)
Metabolic disorders (9)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (36)
NextGen: Class of 2026 (132)
Non-profit (101)
Obesity (6)
Opinion (7)
Ovarian cancer (28)
Pain (3)
Pancreatic cancer (106)
Parkinson's disease (5)
Patents (30)
Patient recruitment (68)
People (1276)
Pharmacy benefit managers (1)
Phase 1 (3407)
Phase 2 (4313)
Phase 3 (3436)
Pipeline (646)
Policy (1)
Postmarket research (137)
Preclinical (720)
Prostate cancer (151)
Psychedelics (3)
Radiopharmaceuticals (81)
Rare diseases (28)
Real estate (58)
Regulatory (1761)
Reports (3)
Research institute (138)
RNA editing (1)
RSV (2)
Schizophrenia (2)
Series A (8)
Series B (7)
Special edition (1)
Sponsored (2)
Startups (83)
Stomach cancer (14)
Supply chain (2)
The Weekly (1)
Vaccines (42)
Venture capital (4)
Weight loss (2)
Women's health (1)
Date
Last 7 days (53)
Last 30 days (180)
Last 365 days (2663)
2026 (218)
2025 (2711)
2024 (2974)
2023 (3317)
2022 (3516)
2021 (3430)
2020 (2824)
2019 (1988)
2018 (1426)
2017 (1578)
2016 (1324)
2015 (1756)
2014 (979)
2013 (672)
2012 (701)
2011 (649)
2010 (542)
Location
Africa (8)
Alabama (2)
Arizona (9)
Asia (2780)
Australia (652)
California (972)
Canada (263)
China (218)
Colorado (10)
Connecticut (74)
Delaware (67)
Europe (4601)
Florida (155)
Illinois (56)
India (3)
Indiana (45)
Iowa (9)
Japan (78)
Kansas (2)
Kentucky (10)
Maine (1)
Maryland (137)
Massachusetts (602)
Minnesota (62)
Missouri (3)
New Hampshire (1)
New Jersey (361)
New Mexico (1)
New York (320)
North Carolina (34)
Northern California (459)
Ohio (16)
Oregon (1)
Pennsylvania (170)
South America (16)
South Carolina (1)
Southern California (462)
Tennessee (1)
Texas (209)
United States (3314)
Utah (11)
Virginia (3)
Washington State (65)
Wisconsin (14)
33,377 Results for "metastat".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FRUZAQLA(TM) (fruquintinib capsules) now reimbursed in Ontario to treat metastatic colorectal cancer (mCRC)
February 2, 2026
·
4 min read
Press Releases
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
January 28, 2026
·
6 min read
Press Releases
Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer
February 5, 2026
·
6 min read
Press Releases
AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer
January 30, 2026
·
8 min read
Press Releases
Caris Life Sciences’ Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan
January 29, 2026
·
6 min read
Press Releases
Faron Expands Bexmarilimab Program in Solid Tumors with a Randomized Phase I/II BEXAR IIT in Metastatic Soft-Tissue Sarcoma
January 27, 2026
·
5 min read
Approvals
AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer
Analysts at Jefferies called the approval “highly significant,” estimating it could add $2 billion to $3 billion to peak Enhertu sales.
December 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
OS Therapies Initiates US FDA BLA Filing for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
February 2, 2026
·
6 min read
Press Releases
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
February 2, 2026
·
7 min read
Press Releases
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
February 3, 2026
·
19 min read
1 of 3,338
Next
